|
1
|
Marubashi S, Takahashi A, Kakeji Y,
Hasegawa H, Ueno H, Eguchi S, Endo I, Goi T, Saiura A, Sasaki A, et
al: Surgical outcomes in gastroenterological surgery in Japan:
Report of the national clinical database 2011–2019. Ann
Gastroenterol Surg. 5:639–658. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu D, Lu M, Li J, Yang Z, Feng Q, Zhou M,
Zhang Z and Shen L: The patterns and timing of recurrence after
curative resection for gastric cancer in China. World J Surg Oncol.
14:3052016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kikuchi K, Suda K, Shibasaki S, Tanaka T
and Uyama I: Challenges in improving the minimal invasiveness of
the surgical treatment for gastric cancer using robotic technology.
Ann Gastroenterol Surg. 5:604–613. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marrelli D, Pedrazzani C, Morgagni P, de
Manzoni G, Pacelli F, Coniglio A, Marchet A, Saragoni L, Giacopuzzi
S and Roviello F; Italian Research Group for Gastric Cancer, :
Changing clinical and pathological features of gastric cancer over
time. Br J Surg. 98:1273–1283. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Henson DE, Dittus C, Younes M, Nguyen H
and Albores-Saavedra J: Differential trends in the intestinal and
diffuse types of gastric carcinoma in the United States, 1973–2000:
Increase in the signet ring cell type. Arch Pathol Lab Med.
128:765–770. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laurén PA and Nevalainen TJ: Epidemiology
of intestinal and diffuse types of gastric carcinoma. A time-trend
study in Finland with comparison between studies from high- and
low-risk areas. Cancer. 71:2926–2933. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA;
WHO Classification of Tumours Editorial Board, : The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mariette C, Carneiro F, Grabsch HI, van
der Post RS, Allum W and de Manzoni G; European Chapter of
International Gastric Cancer Association, : Consensus on the
pathological definition and classification of poorly cohesive
gastric carcinoma. Gastric Cancer. 22:1–9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Japanese Gastric Cancer Association.
Japanese classification of gastric carcinoma, . 15th edition.
Tokyo: Kanehara Shuppan; 2017
|
|
11
|
Joypaul BV, Newman EL, Hopwood D, Grant A,
Qureshi S, Lane DP and Cuschieriet A: Expression of p53 protein in
normal, dysplastic, and malignant gastric mucosa: An
immunohistochemical study. J Pathol. 170:279–283. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Horii A, Nakatsuru S, Miyoshi Y, Ichii S,
Nagase H, Ando H, Yanagisawa A, Tsuchiya E, Kato Y and Nakamuraet
Y: Frequent somatic mutations of the APC gene in human pancreatic
cancer. Cancer Res. 52:6696–6698. 1992.PubMed/NCBI
|
|
13
|
Tamura G, Yin J, Wang S, Fleisher AS, Zou
T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, et al:
E-Cadherin gene promoter hypermethylation in primary human gastric
carcinomas. J Natl Cancer Inst. 92:569–573. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ribatti D: Epithelial-mesenchymal
transition in morphogenesis, cancer progression and angiogenesis.
Exp Cell Res. 353:1–5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma HY, Liu XZ and Liang CM: Inflammatory
microenvironment contributes to epithelial-mesenchymal transition
in gastric cancer. World J Gastroenterol. 22:6619–6628. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang X, Zhang P, Shao M, Zang X, Zhang J,
Mao F, Qian H and Xu W: SALL4 activates TGF-β/SMAD signaling
pathway to induce EMT and promote gastric cancer metastasis. Cancer
Manag Res. 10:4459–4470. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakazawa N, Sohda M, Yokobori T, Gombodorj
N, Sano A, Sakai M, Oyama T, Kuwano H, Shirabe K and Saeki H:
Cytoplasmic localization of connexin 26 suppresses transition of
β-catenin into the nucleus in intestinal- and mix-type gastric
cancer. Ann Gastroenterol Surg. 6:505–514. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakazawa N, Sohda M, Ide M, Shimoda Y,
Tateno K, Watanabe T, Sano A, Sakai M, Yokobori T, Ogawa H, et al:
PROX1 was associated with LGR5 and wnt signaling and contributed to
poor prognosis in gastric cancer. Oncology. 100:569–575. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakazawa N, Yokobori T, Kaira K, Turtoi A,
Baatar S, Gombodorj N, Handa T, Tsukagoshi M, Ubukata Y, Kimura A,
et al: High stromal TGFBI in lung cancer and intratumoral
CD8-positive T cells were associated with poor prognosis and
therapeutic resistance to immune checkpoint inhibitors. Ann Surg
Oncol. 27:933–942. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakazawa N, Sohda M, Ide M, Shimoda Y,
Ubukata Y, Kuriyama K, Hara K, Sano A, Sakai M, Yokobori T, et al:
High L-type amino acid Transporter 1 levels are associated with
chemotherapeutic resistance in gastric cancer patients. Oncology.
99:732–739. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakazawa N, Yokobori T, Sohda M, Hosoi N,
Watanabe T, Shimoda Y, Ide M, Sano A, Sakai M, Erkhem-Ochir B, et
al: Significance of lipopolysaccharides in gastric cancer and their
potential as a biomarker for nivolumab sensitivity. Int J Mol Sci.
24:117902023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Xue M, Du S, Feng W, Zhang K, Zhang
L, Liu H, Jia G, Wu L, Hu X, et al: Competitive endogenous RNA is
an intrinsic component of EMT regulatory circuits and modulates
EMT. Nat Commun. 10:16372019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakamura K, Eto K, Iwagami S, Ogawa K,
Sawayama H, Ishimoto T, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N
and Baba H: Clinicopathological characteristics and prognosis of
poorly cohesive cell subtype of gastric cancer. Int J Clin Oncol.
27:512–519. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sarriugarte Lasarte A, García Alberdi E,
Martínez Indart L, Gutiérrez Grijalba O, Álvarez Abad I, Guerra
Lerma M, Calle Baraja M and Colina Alonso A: From Lauren's diffuse
gastric cancer to WHO's poorly cohesive carcinoma.
Clinicopathological and prognostic characteristics. Rev Esp Enferm
Dig. 113:324–331. 2021.PubMed/NCBI
|
|
25
|
Roviello F, Marano L, Ambrosio MR, Resca
L, D'Ignazio A, Petrelli F, Petrioli R, Costantini M, Polom K,
Macchiarelli R, et al: Signet ring cell percentage in poorly
cohesive gastric cancer patients: A potential novel predictor of
survival. Eur J Surg Oncol. 48:561–569. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bencivenga M, Simbolo M, Ciaparrone C,
Vicentini C, Torroni L, Piredda ML, Sacco M, Alloggio M, Castelli
C, Tomezzoli A, et al: Poorly cohesive gastric cancers showing the
transcriptomic hallmarks of epithelial-mesenchymal transition
behave aggressively. Ann Surg. 276:822–829. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bencivenga M, Treppiedi E, Dal Cero MD,
Torroni L, Verlato G, Iglesias M, Renaud F, Tomezzoli A, Castelli
C, Piessen G, et al: The amount of signet ring cells is
significantly associated with tumour stage and survival in gastric
poorly cohesive tumours. J Surg Oncol. 121:1084–1089. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fischer KR, Durrans A, Lee S, Sheng J, Li
F, Wong STC, Choi H, Rayes TE, Ryu S, Troeger J, et al:
Epithelial-to-mesenchymal transition is not required for lung
metastasis but contributes to chemoresistance. Nature. 527:472–476.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim H, Heo YJ, Cho YA, Kang SY, Ahn S and
Kim KM: Tumor immune microenvironment is influenced by frameshift
mutations and tumor mutational burden in gastric cancer. Clin
Transl Oncol. 24:556–567. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koseki Y, Hatakeyama K, Terashima M,
Nagashima T, Urakami K, Ohshima K, Aizawa D, Sugino T, Furukawa K,
Fujiya K, et al: Molecular profile of poorly cohesive gastric
carcinoma with special reference to survival. Gastric Cancer.
26:553–564. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mizoi T, Ohtani H, Miyazono K, Miyazawa M,
Matsuno S and Nagura H: Immunoelectron microscopic localization of
transforming growth factor beta 1 and latent transforming growth
factor beta 1 binding protein in human gastrointestinal carcinomas:
Qualitative difference between cancer cells and stromal cells.
Cancer Res. 53:183–190. 1993.PubMed/NCBI
|
|
34
|
Suzuki M, Yokobori T, Gombodorj N, Yashiro
M, Turtoi A, Handa T, Ogata K, Oyama T, Shirabe K and Kuwano H:
High stromal transforming growth factor β-induced expression is a
novel marker of progression and poor prognosis in gastric cancer. J
Surg Oncol. 118:966–974. 2018. View Article : Google Scholar : PubMed/NCBI
|
